Literature DB >> 25261105

Hypopharyngeal reconstruction: a comparison of three alternatives.

Alaa Eldin Elfeky1, Wail Fayez Nasr, Alaa Khazbak, Mohamed Said Abdelrahman, Zaki Abdelgawad Allam, Wahed Yousry Gareer, Hesham Elsebaey.   

Abstract

This study aimed to evaluate the operative outcomes of using gastric pull-up (GPU), pectoralis major myocutaneous flap (PMMF), and jejunal free flap (JFF) to reconstruct the hypopharynx after resection of hypopharyngeal and cervical esophageal carcinoma. Retrospective clinical study. Otolaryngology Department, Zagazig University Hospital, Egypt and Surgical Department, National Cancer Institute, Cairo, Egypt. Records of 104 patients who underwent resection of carcinoma of the hypopharynx and cervical esophagus were reviewed to determine the indications for radical resection, location, and stage of the primary tumor, gross and pathological surgical resection margins, operative complications, morbidity, and mortality. Reconstruction was performed using the GPU for group (1) (n = 33), PMMF for group (2) (n = 34), and JFF for group (3) (n = 37). The hypopharynx was the most common primary tumor site for group (2) and group (3) whereas group (1) had lesions more frequently in the cervical esophagus. The overall postoperative morbidity rate was 20.2% with a perioperative mortality rate of 6.7% and there was no significant difference between the three groups. There was no graft necrosis in group (1) compared to 5.9% in group (2) and 5.4% in group (3). Pulmonary complications occurred commonly (30.3%) in group (1) compared to 11.8% in group (2) and 10.8% in group (3) The overall 3 years survival rate was 67.3% and there was no significant difference between the three groups. The outcomes of the three techniques are equally successful when used appropriately. The nature of the defect indicates the method of reconstruction. For short reconstruction above the thoracic inlet, PMMF or JFF are equally effective and in tumors requiring total esophagectomy, GPA is indicated.

Entities:  

Mesh:

Year:  2014        PMID: 25261105     DOI: 10.1007/s00405-014-3306-x

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  20 in total

Review 1.  [Malpighian carcinoma of the thoracic esophagus: what x-ray computed tomographic classification?].

Authors:  A Wurtz; P Chastanet
Journal:  Gastroenterol Clin Biol       Date:  1988-12

2.  Pharyngolaryngectomy, with immediate pharyngogastric anastomosis.

Authors:  L P Le Quesne; D Ranger
Journal:  Br J Surg       Date:  1966-02       Impact factor: 6.939

3.  Complications of the pectoralis major myocutaneous flap in head and neck reconstruction.

Authors:  J P Shah; V Haribhakti; T R Loree; P Sutaria
Journal:  Am J Surg       Date:  1990-10       Impact factor: 2.565

4.  Pharyngogastric anastomosis following pharyngolaryngoesophagectomy. Analysis of 157 cases.

Authors:  K H Lam; J Wong; S T Lim; G B Ong
Journal:  World J Surg       Date:  1981-07       Impact factor: 3.352

5.  Jejunal free flap reconstruction of the pharyngolaryngectomy defect: 368 consecutive cases.

Authors:  Diana Perez-Smith; Michael Wagels; David R Theile
Journal:  J Plast Reconstr Aesthet Surg       Date:  2012-09-18       Impact factor: 2.740

6.  Surgical management of carcinoma of the hypopharynx and cervical esophagus.

Authors:  A Peracchia; R Bardini; A Ruol; A Segalin; C Castoro; M Asolati; E Tiso
Journal:  Hepatogastroenterology       Date:  1990-08

7.  Free jejunal graft for hypopharyngeal and esophageal reconstruction.

Authors:  Yasuhiro Shirakawa; Yoshio Naomoto; Kazuhiro Noma; Ryoko Ono; Tetsuji Nobuhisa; Masahiko Kobayashi; Toshiya Fujiwara; Hirofumi Noguchi; Takaomi Ohkawa; Tomoki Yamatsuji; Minoru Haisa; Junji Matsuoka; Mehmet Gunduz; Noriaki Tanaka
Journal:  Langenbecks Arch Surg       Date:  2004-07-09       Impact factor: 3.445

8.  Review of 346 patients with free-flap reconstruction following head and neck surgery for neoplasm.

Authors:  S Podrecca; P Salvatori; M Squadrelli Saraceno; D Fallahdar; L Calabrese; G Cantù; R Molinari
Journal:  J Plast Reconstr Aesthet Surg       Date:  2006       Impact factor: 2.740

9.  Gastric transposition for head and neck cancer: a critical update.

Authors:  R H Spiro; M S Bains; J P Shah; E W Strong
Journal:  Am J Surg       Date:  1991-10       Impact factor: 2.565

10.  Therapeutic options for cancer of the hypopharynx and cervical oesophagus.

Authors:  R Bardini; A Ruol; A Peracchia
Journal:  Ann Chir Gynaecol       Date:  1995
View more
  6 in total

Review 1.  Reconstructive Trends in Post-Ablation Patients with Esophagus and Hypopharynx Defect.

Authors:  Sae Hwi Ki; Jong Hwan Choi; Seung Hyun Sim
Journal:  Arch Craniofac Surg       Date:  2015-12-09

2.  Successful management of the supraclavicular artery island flap combined with a sternohyoid muscle flap for hypopharyngeal and laryngeal reconstruction.

Authors:  Qinying Wang; Ruixiang Chen; Shuihong Zhou
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

3.  Unplanned change from double free flap to a chimeric anterolateral thigh flap in recurrent laryngeal cancer.

Authors:  Sae Hwi Ki; Sung Hwan Ma; Seung Hyun Sim; Matthew Seung Suk Choi
Journal:  Arch Craniofac Surg       Date:  2019-12-20

4.  Jejunal and ileocolic free flaps for digestive tract reconstruction following pharyngo-laryngo-oesophagectomy - 30 years of single-centre experience.

Authors:  Ewa Osuch-Wójcikiewicz; Daniel Majszyk; Antoni Bruzgielewicz; Tadeusz Grochowiecki; Sławomir Nazarewski; Piotr Chęciński; Kazimierz Niemczyk
Journal:  Contemp Oncol (Pozn)       Date:  2021-04-15

5.  Use of Supraclavicular Flap by End to Side Technique in Pharyngeal SCC: A Case Report and Review of Literature.

Authors:  Aslan Ahmadi; Ayda Sanaei; Delaram Jan; Maryam Zolfaghary
Journal:  Case Rep Otolaryngol       Date:  2021-07-14

6.  Hypopharynx reconstruction for primary hypopharyngeal carcinoma: a retrospective study and literature review.

Authors:  Yu Heng; Duo Zhang; Xiaoke Zhu; Liang Zhou; Ming Zhang; Kenan Li; Lei Tao
Journal:  Transl Cancer Res       Date:  2021-07       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.